|
AU572125B2
(en)
*
|
1983-03-17 |
1988-05-05 |
Mabco Limited |
Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
|
WO1993010260A1
(en)
|
1991-11-21 |
1993-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
|
US5648267A
(en)
|
1992-11-13 |
1997-07-15 |
Idec Pharmaceuticals Corporation |
Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
|
|
CU22615A1
(es)
|
1994-06-30 |
2000-02-10 |
Centro Inmunologia Molecular |
Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
|
|
CA2194907A1
(en)
|
1994-07-13 |
1996-02-01 |
Kouji Matsushima |
Reshaped human antibody against human interleukin-8
|
|
US5986065A
(en)
*
|
1997-03-10 |
1999-11-16 |
Sunol Molecular Corporation |
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
ES2434961T5
(es)
|
1998-04-20 |
2018-01-18 |
Roche Glycart Ag |
Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
|
|
ES2639222T5
(es)
|
2000-10-06 |
2023-11-24 |
Kyowa Kirin Co Ltd |
Células que producen unas composiciones de anticuerpo
|
|
EP1345967B1
(en)
|
2000-12-22 |
2011-08-10 |
Grad, Carole, Legal representative of Kaplan, Howard |
Phage display libraries of human v h fragments
|
|
CN100506277C
(zh)
|
2001-11-01 |
2009-07-01 |
Uab研究基金会 |
肿瘤坏死因子相关细胞凋亡诱导配体受体的选择性抗体和其它治疗剂的联合体系
|
|
AU2003277832A1
(en)
*
|
2002-10-31 |
2004-05-25 |
Novo Nordisk A/S |
Humanized tissue factor antibodies
|
|
KR20060035608A
(ko)
*
|
2003-05-30 |
2006-04-26 |
센토코 인코포레이티드 |
항 조직 인자 항체로 종양 성장을 저해하는 방법
|
|
US8722044B2
(en)
*
|
2011-03-15 |
2014-05-13 |
Janssen Biotech, Inc. |
Human tissue factor antibody and uses thereof
|
|
DK2907824T3
(en)
|
2012-10-11 |
2018-07-23 |
Daiichi Sankyo Co Ltd |
ANTIBODY-drug conjugate
|
|
CA2937034A1
(en)
|
2014-02-03 |
2015-08-06 |
Riken |
Anti-tissue factor monoclonal antibody
|
|
JP2017114763A
(ja)
*
|
2014-03-26 |
2017-06-29 |
第一三共株式会社 |
抗ｃｄ９８抗体−薬物コンジュゲート
|
|
EP3502141A4
(en)
*
|
2016-08-22 |
2020-04-08 |
Fudan University |
ANTIBODIES TAKEN AGAINST THE TISSUE FACTOR, MANUFACTURING METHODS THEREFOR AND USE THEREOF
|
|
TW201922796A
(zh)
*
|
2017-10-30 |
2019-06-16 |
國立研究開發法人國立癌症研究中心 |
可用於實體腫瘤治療之抗體及其抗體－藥物共軛物以及含其之抗癌劑
|
|
MX2020005473A
(es)
*
|
2017-11-27 |
2020-08-27 |
Purdue Pharma Lp |
Anticuerpos humanizados que se dirigen al factor tisular humano.
|
|
EP3735271A4
(en)
*
|
2018-01-04 |
2022-06-15 |
Iconic Therapeutics, Inc. |
ANTI-TISSUE FACTOR ANTIBODIES, ANTIBODY DRUG CONJUGATES AND RELATED METHODS
|
|
TW202537643A
(zh)
*
|
2018-07-31 |
2025-10-01 |
日商第一三共股份有限公司 |
抗體-藥物結合物之用途
|
|
TW202019487A
(zh)
*
|
2018-08-06 |
2020-06-01 |
日商第一三共股份有限公司 |
抗體-藥物結合物及微管蛋白抑制劑之組合
|
|
AU2019321442A1
(en)
*
|
2018-08-16 |
2021-02-11 |
Genmab A/S |
Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer
|